These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19279304)

  • 21. High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: a multicenter screening study.
    Scheuing N; Holl RW; Dockter G; Hermann JM; Junge S; Koerner-Rettberg C; Naehrlich L; Smaczny C; Staab D; Thalhammer G; van Koningsbruggen-Rietschel S; Ballmann M
    PLoS One; 2014; 9(11):e112578. PubMed ID: 25393021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
    Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
    J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous glucose monitoring in a cystic fibrosis patient to predict pulmonary exacerbation?
    Inman TB; Proudfoot JA; Lim M; Demeterco-Berggren C
    J Cyst Fibros; 2017 Sep; 16(5):628-630. PubMed ID: 28625799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
    Armaghanian N; Hetherington J; Parameswaran V; Chua EL; Markovic TP; Brand-Miller J; Steinbeck K
    Pediatr Pulmonol; 2020 Dec; 55(12):3391-3399. PubMed ID: 32955169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects.
    De Block C; Vertommen J; Manuel-y-Keenoy B; Van Gaal L
    Curr Diabetes Rev; 2008 Aug; 4(3):159-68. PubMed ID: 18690896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
    Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
    Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis.
    Declercq D; Helleputte S; Marchand S; Van Aken S; Van Braeckel E; Van Daele S; T'Sjoen G; Van Biervliet S; Lapauw B
    J Cyst Fibros; 2023 Jan; 22(1):59-65. PubMed ID: 36068119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose intolerance in children with cystic fibrosis: a developing country's perspective.
    Banavath LN; Kumar R; Dayal D; Yadav J; Sachdeva N; Mathew JL; Vaidya PC; Singh M
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1139-1146. PubMed ID: 30244233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous glucose monitoring in cystic fibrosis - A practical guide.
    Chan CL; Ode KL; Granados A; Moheet A; Moran A; Hameed S
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S25-S31. PubMed ID: 31679725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pH, lactate, hematocrit and potassium level on the accuracy of continuous glucose monitoring (CGM) in pediatric intensive care unit.
    Marics G; Koncz L; Eitler K; Vatai B; Szénási B; Zakariás D; Mikos B; Körner A; Tóth-Heyn P
    Ital J Pediatr; 2015 Mar; 41():17. PubMed ID: 25888142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous glucose monitoring to evaluate glycaemic abnormalities in cystic fibrosis.
    Zorrón Mei Hsia Pu M; Gonçalves AC; Minnicucci WJ; Morcillo AM; Ribeiro JD; Ribeiro AF
    Arch Dis Child; 2018 Jun; 103(6):592-596. PubMed ID: 29378680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.
    Chan CL; Vigers T; Pyle L; Zeitler PS; Sagel SD; Nadeau KJ
    J Cyst Fibros; 2018 Nov; 17(6):783-790. PubMed ID: 29580828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of continuous glucose monitoring in normoglycemic, insulin-resistant women.
    Hasson RE; Freedson PS; Braun B
    Eur J Appl Physiol; 2010 Apr; 108(6):1181-7. PubMed ID: 20033205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
    Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
    J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous glucose monitoring time series and hypo/hyperglycemia prevention: requirements, methods, open problems.
    Sparacino G; Facchinetti A; Maran A; Cobelli C
    Curr Diabetes Rev; 2008 Aug; 4(3):181-92. PubMed ID: 18690899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.